These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31729306)

  • 1. The Impact of Spironolactone on Markers of Myocardial Oxidative Status, Inflammation and Remodeling in Hyperthyroid Rats.
    Mayyas FA; Aljohmani AI; Alzoubi KH
    Curr Mol Pharmacol; 2020; 13(3):206-215. PubMed ID: 31729306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin-induced diabetes.
    Mayyas F; Alzoubi KH; Bonyan R
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27992114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.
    Donderski R; Stróżecki P; Sulikowska B; Grajewska M; Miśkowiec I; Stefańska A; Siódmiak J; Odrowąż-Sypniewska G; Manitius J
    Int Urol Nephrol; 2017 Oct; 49(10):1867-1873. PubMed ID: 28710615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone effects on myocardium changes induced by thyroid hormone in rats.
    Fernandes ML; Ferro EA; Beletti ME; Resende ES
    Arq Bras Cardiol; 2007 Dec; 89(6):398-402. PubMed ID: 18317623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.
    Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
    Buss SJ; Backs J; Kreusser MM; Hardt SE; Maser-Gluth C; Katus HA; Haass M
    Endocrinology; 2006 May; 147(5):2526-34. PubMed ID: 16439456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress induced by thyroid dysfunction in rat erythrocytes and heart.
    Messarah M; Saoudi M; Boumendjel A; Boulakoud MS; Feki AE
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):33-41. PubMed ID: 21787667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
    Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL
    Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fish oil in attenuating cardiac oxidative stress, inflammation and fibrosis in rat model of thyrotoxicosis.
    Mayyas F; Alsaheb A; Alzoubi KH
    Heliyon; 2019 Dec; 5(12):e02976. PubMed ID: 31872133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
    Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
    Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
    Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
    Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
    Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
    Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
    Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt sensitivity in experimental thyroid disorders in rats.
    Perez-Abud R; Rodríguez-Gómez I; Villarejo AB; Moreno JM; Wangensteen R; Tassi M; O'Valle F; Osuna A; Vargas F
    Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E281-7. PubMed ID: 21521719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of oxidative stress in plasma and tissues of rats with experimentally induced hyperthyroidism by caffeic acid phenylethyl ester.
    Mohamadin AM; Hammad LN; El-Bab MF; Abdel Gawad HS
    Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):84-90. PubMed ID: 17244256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
    Zhang L; Hao JB; Ren LS; Ding JL; Hao LR
    Lab Invest; 2014 Aug; 94(8):839-50. PubMed ID: 24862968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
    Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
    Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Arginase Inhibition in Hypertensive Hyperthyroid Rats.
    Rodríguez-Gómez I; Manuel Moreno J; Jimenez R; Quesada A; Montoro-Molina S; Vargas-Tendero P; Wangensteen R; Vargas F
    Am J Hypertens; 2015 Dec; 28(12):1464-72. PubMed ID: 25907224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes.
    Queisser N; Happ K; Link S; Jahn D; Zimnol A; Geier A; Schupp N
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):399-407. PubMed ID: 25204689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.